Clinical updates, including trial initiations, enrollment status and data readouts and publications: Smith+Nephew.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abionyx, Antengene, ASC, Biogen, Guerbet, Hipra, Nurix, Realta, Receptor, Taiho, Viiv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acer, Adagio, Ascletis, Cellphire, Concentric, Genentech, Immutep, Prometheus, Revelation.

Adagio Therapeutics Inc. plans to file for emergency use authorization in the second quarter of 2022 for its lead candidate, a monoclonal antibody (MAb) for preventing and treating COVID-19. With plenty of competing vaccines around, the company now thinks it has found the right group to receive it: the immunocompromised.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Masimo, O'Brien, Synchron, University of Portsmouth.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Antares, Astrazeneca, BMS, Canbridge, CSL, Daewoong, Enanta, Immunogen, Mitsubishi Tanabe, Neurocrine, Novo Nordisk, Noxopharm, Reveragen, Santhera, Takeda, Urogen, Telix.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AB, Acelrx, Adocia, Alpha Cognition, Asahi Kasei, Athos, Biosion, Biovaxys, Bone Therapeutics, Brii, Collegium, Cybin, Diurnal, Elicio, Formycon, Graybug, Orchard, Organo, Partner, Polpharma, Pyxis, Qpex, Rainbio, Redx, Scenic, Sinopharm, Sterotherapeutics, Teva, TSB, Vectivbio, Vector, Vyant and Vyne.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Albireo, Aldeyra, Angiocrine, Antios, Aptevo, Bio-Thera, Cullinan, Curevac, Design, Diamond, Galecto, Glaxosmithkline, HDT, Innovent, Krystal, Lannett, Maat, Neuronascent, Neuroplast, Ocuphire, Pfizer, Recce, Recordati, Rejuvenate, Revive, Ribon, Sangamo, Saniona, Scancell, Sumitomo Dainippon, Synthetic, Valbiotis, Vectivbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Carthera, Focalyx Technologies, Lucira Health.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Biontech, Blue Lake, Cormedix, CSL, Cynavac, Galapagos, GSK, Hansa, Helsinn, Immorna, Innocare, Medison, Moberg, Moderna, Pfizer, Pipeline, Sanofi, Seqirus, Stealth, Tolerogenixx, UCB, Vir.